Dr. Albert Bourla of Pfizer Becomes New Chair of PhRMA Board

The Pharmaceutical Research and Manufacturers of America (PhRMA) today announced that Pfizer Chairman and Chief Executive Officer, Dr. Albert Bourla, has assumed the role of chair of the PhRMA Board of Directors. PhRMA also announced that Paul Hudson, Chief Executive Officer at Sanofi, has become board chair-elect and Robert Davis, Chairman and Chief Executive Officer at Merck, will serve as treasurer.